*Vibrio parahaemolyticus,* a kind of Gram-negative motile bacteria inhabiting marine and estuarine environments throughout the world ([@B161]), is a major food-borne pathogen that causes diarrhea primarily after the consumption of raw or undercooked seafood ([@B11]; [@B78]). To ensure its survival in varying environments, *V. parahaemolyticus* has two different types of flagellar systems, allowing it to adapt to constantly changing environments. The polar flagellum is responsible for swimming ([@B12]), whereas the lateral flagella are closely associated with the swarmer cell type transformation and biofilm formation (**Figure [1](#F1){ref-type="fig"}**). During infection, *V. parahaemolyticus* uses the adhesion factors to bind to the fibronectin and phosphatidic acid on the host cell, thus releasing different effectors and toxins into the cytoplasm, causing cytotoxicity and serious diseases ([@B46]). *V. parahaemolyticus* is a multiserotype bacterium, containing at least 12 different O antigens and more than seventy different K antigens in its capsule. Consequently, serotyping has been widely used to detect *V. parahaemolyticus* and to study its pathogenesis ([@B171]). Among the serotypes, three serotypes (O3:K6, O4:K68, and O1:K untypeable) are extremely virulent and pathogenic to humans, and are regarded as the major agents of food-borne diseases ([@B74]). To date, the genomes of six strains from these different serotypes have been sequenced: strains RimD221063 and AQ3810 from O3:K6, the strains AN-5034, K5030, and Peru-466 from O4:K68, and the strain Vp10329 from O4:K12 ([@B94]; [@B12]; [@B47]). The first fully sequenced and annotated genome of strain RimD221063 has been used as the reference sequence in cell biological and pathogenetic analysis of numerous clinical and environmental *V. parahaemolyticus* strains ([@B94]).

![**Structures and virulence factors of *V. parahaemolyticus*.** *V. parahaemolyticus* contains two T3SS systems, two T6SS systems, and expresses many toxins, including TLH, TRH, and TDH. MAM7 is responsible for its initial attachment to host cells. This bacterium has two different flagellar systems, allowing it to adapt to changing environments. The polar flagellum is responsible for swimming, whereas the lateral flagella are closely related to the swarmer cell transformation and biofilm formation.](fmicb-06-00144-g001){#F1}

DISEASE CAUSED BY *V. parahaemolyticus*
=======================================

In 1950, an first outbreak of disease caused by *V. parahaemolyticus* in the city of Osaka city of Japan was first reported, with acute gastroenteritis in 272 individuals, 20 of whom died ([@B41]; [@B33]). Since then, 802 outbreaks of food-borne diseases have been reported in 13 of the coastal provinces of eastern China, causing 17,462 individuals to become ill ([@B161]). *V. parahaemolyticus* (40.1%) accounted for the greatest number of these outbreaks and cases ([@B90]; [@B22]). Similar diseases have also been frequently reported in many countries in Asia, Europe, Africa, and in the Americans ([@B37]; [@B2]; [@B92]; [@B96]; [@B152]; [@B23]). *V. parahaemolyticus* infection is also disseminated through open wounds, and often causes septicemia in severe cases ([@B165]). Recently, *V. parahaemolyticus* has been reported to be the major agent of acute hepatopancreatic necrosis syndrome aﬄicting penaeid shrimp, and has seriously damaged the shrimp aquaculture industry ([@B157]).

The food poisoning caused by *V. parahaemolyticus* usually occurs in summer (from June to October), and is predominantly associated with different kinds of seafood, including crab, shrimp, shellfish, lobster, fish, and oysters ([@B85]; [@B106]; [@B73]; [@B32]; [@B88]). Among the whole range of seafood, shellfish is regarded as a high-risk food because it is infested with large populations of bacteria, including *V. parahaemolyticus,* to levels higher than those in the surrounding water ([@B122]; [@B5]). Once consumers eat undercooked, contaminated seafood, illness is inevitable ([@B132]). The typical clinical symptoms of *V. parahaemolyticus* poisoning are acute dysentery and abdominal pain, accompanied by diarrhea, nausea, vomiting, fever, chills, and water-like stools ([@B174]; [@B144]). The feces of patients are mixed with mucus or blood, and their blood pressure decreases dreamily, leading to shock ([@B12]). Some severely affected patients become unconsciousness, show recurrent convulsions, become pale or cyanotic, and even death ([@B105]). The distinct pathological changes in patients include the mild erosion of the jejunum and ileum, gastric inflammation, and internal organ damage (liver, spleen, lung congestion, etc.). To cure *V. parahaemolyticus* infection effectively, common treatment methods include antibiotics and oral rehydration. To avoid intense illness, it is recommended that some subpopulations, including patients suffering severe physical or immunodeficiency diseases, do not consume the seafood ([@B8]; [@B60]).

PATHOGENESIS OF *V. parahaemolyticus*
=====================================

HEMOLYSIN, UREASE, AND PATHOGENESIS
-----------------------------------

Thermostable direct hemolysin (TDH) and TDH-related hemolysin (TRH) are two major virulence factors of *V. parahaemolyticus*, and are closely related to its pathogenicity (**Table [1](#T1){ref-type="table"}**). They have similar hemolytic activity *in vitro* and cause the lysis of human erythrocytes in excessively saline medium ([@B139]; [@B103]; [@B66]; [@B63]). An epidemiological investigation indicated that TDH is one of the major pathogenic factors in *V. parahaemolyticus*, and is prevalent in almost all (95%) of clinical isolates. When secreted, it can lyse red blood cells and produces a special hemolysis ring on Wagatsuma blood agar plates ([@B110]; [@B62]; [@B89]). This is also known as "Kanagawa phenomenon" and is reported to be commonly associated with gastroenteritis ([@B103]; [@B75]). Previous reports have shown that two enzymatic activities of TDH are associated with bacterial pathogenesis. One is a hemolytic activity that is independent of lipid rafts. TDH binds to the membranes of red blood cells or host cells, and forms a pore on the membrane surface, ultimately leading to the permeation of the colloids of red blood cells ([@B99]). The other enzymatic activity is its cytotoxicity, TDH causes cells toxicity and forms a channel in the cell membrane, which induces an increase in the extracellular Ca^2+^ concentration and Cl^-^ secretion ([@B99]). When the osmotic pressure of the cell exceeds the upper limit for cell self-regulation, pathological and morphological changes were occur in the cell, resulting in cell expansion and even death. Like TDH, TRH causes similar levels of hemolysis *in vitro* ([@B154]; [@B21]).

###### 

List of known virulence factors of *V. parahaemolyticus.*

  Effectors             Gene        Biological activity                                  Effects on host cells
  --------------------- ----------- ---------------------------------------------------- --------------------------------------------------------
  **Toxins**                                                                             
  TDH                   *tdh*       Forms pores on cells                                 Cytotoxicity and enterotoxicity
  TRH                   *trh*       Forms pores on cells                                 Cytotoxicity and enterotoxicity
  TLH                   *tlh*       Hemolysin activity or?                               Cytotoxicity and ?
  **T3SS1 effectors**                                                                    
  Vop Q                 *vp1680*    Forms pores and binds V-ATPase                       Autophagy, cell lysis, MAPK activation, IL-8 secretion
  Vop S                 *vp1686*    Inhibition of Rho by AMPylation                      Cells rounding, phagocytes invasion
  VPA0450               *vpa0450*   Phosphatidylinositol phosphatase                     Membrane blebbing, destabilization
  Vop R                 *vp1683*    Binds PIP2 in membrane                               Promoting refolding of T3SS effectors
  **T3SS2 effectors**                                                                    
  Vop A/P               *vpa1346*   Inhibition of MAPK by acetylation of MKK             Blocking of phosphorylation and ATP binging
  Vop T                 *vpa1327*   Ras ADP-ribosylation                                 Cytotoxicity and yeast growth inhibition
  Vop L                 *vpa1370*   Actin nucleation                                     Stress fibers formation and cell shape changing
  Vop C                 *vpa1321*   Activation of Rac and CDC42 by deamidation           Invasion of non-phagocytic cells
  Vop V                 *vpa1357*   Actin binding and bundling                           Enterotoxicity and blunting of villi
  Vop Z                 *vpa1336*   Inhibition of TAK1 and downstream MAPK and NF-~k~B   Enterotoxicity and colonization
  VPA1380               *vpa1380*   Cysteine catalysis dependent on IP6                  Toxicity in yeast

Thermolabile hemolysin (TLH) is another hemolysin of *V. parahaemolyticus*, encoded by the *tlh* gene, and also causes the lysis of red blood cells ([@B145]; [@B101]; [@B164]). TLH is expressed by all clinical and environmental strains of *V. parahaemolyticus* ([@B7]), and the gene is significantly upregulated under simulated intestinal infection conditions ([@B48]; **Table [1](#T1){ref-type="table"}**). Besides, TLH shows typical lecithin-dependent phospholipase activity, and it also lyses human erythrocytes ([@B12]). Therefore, it may play a key role in the process of human infection. Recent, studies have demonstrated that all three types of cells (Hela, Changliver, and RAW264.7 cells) display signs of severe cytotoxicity when treated with the purified TLH protein, and its effects are dose and time-dependent ([@B165]). Therefore, TLH may have similar biological functions similar to these of the TDH and TRH toxins, playing a key role in the *V. parahaemolyticus* infection. Early studies showed that urease induces the accumulation of intestinal fluid in the rabbit ileal loops test and causes gastrointestinal inflammatory lesions, confirming that urease is an important virulence factor in *trh*^+^ *V. parahaemolyticus* strains ([@B17]; [@B116]). Urease is encoded by the *Uh* gene, and is generally involved in the formation of ammonia during the process of infection ([@B86]).

T3SS1 INDUCES AUTOPHAGY AND CYTOTOXICITY
----------------------------------------

The type III secretion systems (T3SSs) are transmembrane apparatuses formed by the multicomponent protein complexes ([@B28]), that allow effectors or virulence proteins to be injected directly into the cytoplasm of the host cell ([@B36]; [@B24]). There are two different T3SS systems in *V. parahaemolyticus*, designated T3SS1 and T3SS2 ([@B94]). T3SS1 is located on chromosome I, is encoded by the first pathogenicity island, and is present in almost every clinical and environmental *V. parahaemolyticus* strains ([@B117]). T3SS1 gene expression is regulated by three exoenzyme S synthesis proteins (ExsC, ExsD, and ExsE) and heat-stable nucleoid structuring protein (H-NS; [@B81]; [@B183]). Several studies have shown that T3SS1 is cytotoxic, causing autophagy, cell rounding, and finally death ([@B16]; [@B58]; [@B114]; [@B135]; [@B179]). To date, four effectors have been determined in T3SS1 (**Table [1](#T1){ref-type="table"}**): Vop Q, Vop S, VPA0450, and Vop R (VP1638), correspondingly ([@B13]; [@B93]; [@B140]; [@B150]; **Figure [2](#F2){ref-type="fig"}**).

![**Activities of T3SS1 effectors in cultured intestinal epithelial cells.** Vop Q inhibits the MAPK pathway by acetylating MKK, and Vop S inhibits Rho by AMPylation, leading to cells rounding and phagocytes invasion. VPA0450 hydrolyzes phosphatidylinositide (4, 5)-bisphosphate (PI(4,5)P2) to D5 phosphate (PI4P) and disrupts the association between the membrane and the actin cytoskeleton, leading to membrane blebbing. Vop R binds to PIP2 in the membrane, thus promoting the refolding of the T3SS effectors.](fmicb-06-00144-g002){#F2}

The effector Vop Q ([@B118]) is necessary for the formation of autophagic vesicles in the process of *V. parahaemolyticus* infection ([@B100]). Many researchers have confirmed that the *V. parahaemolyticus* strain in which T3SS1 is deleted can be easily engulfed and degraded by macrophages, causing the apoptosis of the infected cells ([@B15]; [@B150]). These results indicate that T3SS1 effectively inhibits the ability of the host cells to phagocytose *V. parahaemolyticus* ([@B72]). Vop Q is also reported to be an activator of the JNK, p38, and MAPK pathways in Caco-2 cells, and interacts with the C subunit of the vacuolar H^+^-ATPase ([@B98]; [@B124]), leading to the secretion of the chemokine interleukin 8 (IL-8; [@B143]).

Vop S, another effector secreted by T3SS1, causes the death of macrophages by inhibiting NF-κB activity. Vop S contains a Fic domain at its C terminus, and also prevents actin aggregation and rapid re-aggregation by AMPylating the Rho family GTPases ([@B20]; [@B173]; [@B93]), resulting in the rounding of the infected cells ([@B79]). This change allows the pathogen to suppress the phagocytosis of infected cells by macrophages ([@B56]). Vop S also has exerts certain cytotoxicity effects on Hela cells.

VPA0450 is a typical phosphatidylinositide phosphatase, hydrolyzing phosphatidylinositide (4, 5)-bisphosphate (PI(4,5)P2) to D5 phosphate (PI4P; [@B82]). The resulting product, PI4P, disrupts the association between the membrane and the actin cytoskeleton, leading to membrane blebbing ([@B13]). VPA0450 induces cell rounding and lysis by destroying the dynamics of the plasma membrane cytoskeleton, and it may play a complementary role with other effectors in the infection process ([@B13]).

Vop R is encoded by the *vp1683* gene and is secreted by T3SS1. It also contains a similar phosphoinositide-binding domain (BPD) that is conserved in diverse type III effectors of both plant and animal pathogens ([@B140]). Vop R localizes to the host membrane by its N-terminal domain and specifically binds the phosphoinositide on the host cell. It may also play a key role in promoting the refolding of Type III effectors after their delivery into the host cells ([@B45]; [@B55]; [@B140]).

T3SS2 MEDIATES ENTEROTOXICITY AND CYTOTOXICITY
----------------------------------------------

T3SS2, a newly identified type of secretion system, is encoded by a pathogenicity island (*VP-PAL*) on chromosome II, and is found primarily in clinical isolates ([@B102]). T3SS2 has been associated with enterotoxicity in the rabbit ileal loop model, infant rabbits and piglets ([@B94]; [@B117]), and has also been shown to cause cytotoxicity in intestinal cell lines such as Caco-2 cells and HCT cells ([@B119]; [@B58]; [@B134]; **Figure [3](#F3){ref-type="fig"}**). Seven known effectors have so far been identified and characterized in T3SS2 (**Table [1](#T1){ref-type="table"}**): Vop C, Vop T, Vop Z, Vop A/P, Vop V, Vop L, and VPA1380 ([@B158]; [@B80]; [@B91]; [@B175]; [@B178]; [@B18]).

![**Activities of the T3SS2 effectors in intestinal epithelial cells during infection.** Vop C deamidates small GTPases such as Rac and CDC42, inducing bacterial invasion. Vop L dimerizes through its VCD domain, thus promoting actin bundling. Vop A inhibits MAPK by acetylating of MKK. Vop V binds directly to F-actin through its long repeat (LR) and C-terminal domain, forming the stress fibers. Vop T modifies Ras with ADP-ribose, and triggers yeast growth inhibition and cytotoxicity in intestinal cells. Vop Z inhibits the activation of the MAPK and NF-κB pathways by repressing of TAK1 kinase. VPA1380 catalyzes it targeted substrate.](fmicb-06-00144-g003){#F3}

Vop A/P (VPA1346) is an acetyltransferase with 55% homology to Yop J of *Yersinia* spp. ([@B94]), which blocks the MAPKs signaling pathway by inhibiting the start and biological activity of mitogen-activated protein kinase ([@B158]), thereby suppressing cell division *via* a new mechanism. Vop L (VPA1370) contains three Wiskott Aldrich homology 2 (WH2) domains and a C-terminal domain (VCD; [@B107]; [@B175]), which generally induces the formation of polarized actin fibers and accelerates the gathering of actin filaments by binding to actin monomers ([@B91]). Notably, Vop L may provide a favorable microenvironment in which bacteria can replicate, thereby enhancing the uptake and invasion of *V. parahaemolyticus.*

Vop C disturbs the actin network and causes bacterial invasion by deamidating glutamine 61 in both Rac and CDC42, which occurs in their switch regions, resulting in the constitutive activation of the Rho family GTPases ([@B40]; [@B178]). The actin cytoskeletons of infected cells are further rearranged with the modification of these GTPases, thereby prompting the infected cells to engulf the bacteria ([@B178]). Vop T modifies the small G protein with ADP-ribose using NAD^+^ as the substrate *in vivo* and *in vitro* ([@B39]; [@B6]). Vop T inhibits yeast cell growth and is cytotoxic for Caco-2 and HCT-8 cells ([@B80]).

Vop V has long repeat (LR) regions in its N- and C-terminal domains, composed of three types of repeated sequence units. It predominantly induces the enterotoxicity observed in the rabbit ileal loop model ([@B59]), and binds directly to F-actin, a polymeric form of actin, leading to the accumulation of F-actin filaments beneath the bacterial microcolonies in Caco-2 cells ([@B51]). All the above results indicate that F-actin binding is required for the enterotoxicity caused by Vop V ([@B59]). However, the molecular mechanism of this enterotoxicity is still unclear, so further investigations are needed for underlying its crucial role during infection.

Vop Z, a novel effector secreted by the T3SS2 system, is responsible for fluid accumulation, cell detachment, and epithelial damage ([@B182]). Intestinal colonization by *V. parahaemolyticus* and fluid accumulation are reduced when Vop Z is deleted ([@B182]). Vop Z inhibits the activation of the MAPK and NF-κB signaling pathways by inhibiting the activation of the TAK1 kinase, resulting in a marked lesion, disrupting on the integrity of the tissue ([@B76]; [@B182]). Therefore, it plays a critical role in the virulence of *V. parahaemolyticus.*

VPA1380 was recently identified as a critical effector of *V. parahaemolyticus* translocated by T3SS2 ([@B59]). It was detrimental to and exerted a toxic effect on yeast growth when it was expressed as an enhanced green fluorescent protein (eGFP) fusion protein, when yeast was used as a heterologous eukaryotic system ([@B18]). Bioinformatic analyses revealed that VPA1380 contains several inositol hexakisphosphate (IP6)-inducible cysteine protease domains, which are known to occur in large known toxins produced by other bacteria ([@B125]; [@B127]). VPA1380 is reported to be a typical cysteine protease, catalyzing its targeted substrate ([@B18]), so VPA1380 is possibly involved in the invasion of host cells by *V. parahaemolyticus*.

T6SS AND PATHOGENESIS
---------------------

Recently, a type VI secretion system (T6SS) has been identified, and detected in many Gram-negative bacteria. It is a macromolecular machine consisting of a multicomponent protein complex ([@B61]). T6SS is responsible for delivering a series of toxic effector proteins into the cytoplasm of eukaryotic cells, allowing the effectors to disrupt the innate immune system and to kill the host cells ([@B29]). The T6SS organelle is functionally analogous to T3SS, and may have a critical function in the process of bacterial infection ([@B140]). Interestingly, *V. parahaemolyticus* contains two different T6SS systems, designated T6SS1 and T6SS2 ([@B10]; [@B176]). T6SS1 is encoded on chromosome I, is predominantly expressed in clinical isolates, and it is most active under warm conditions ([@B113]). T6SS2 has been found in both clinical and environmental isolates, is encoded on chromosome I, and is active under low-salt conditions ([@B141]). A homology analysis indicated that the T6SSs are present in most different *Vibrio* species, including *V. parahaemolyticus*, *V. cholerae, V. harveyi,* and *V. alginolyticus* ([@B129]). Recently published medical research articles have reported that both T6SSs are necessary for the adhesion of *V. parahaemolyticus* to cells and are involved in intracellular trafficking and vesicular transport ([@B10]; [@B176]; [@B141]). Only a few effectors of T6SS from *V. parahaemolyticus* have so far been reported. In recent research, two T6SS effectors that mediate its antibacterial activity were identified using proteomic, bioinformatic, and genetic analyses ([@B142]). VP1388 is encoded within the T6SS1 gene cluster, whereas VPA1263 is encoded on chromosome II ([@B142]). The two effectors contain the conserved MIX motif that is found in proteins with predicted cytotoxic domains, including VgrG and PAAR-repeat-containing protein ([@B128]; [@B147]).

DETECTION METHODS BASED ON VIRULENCE FACTORS
============================================

KANAGAWA TEST
-------------

Thermostable direct hemolysin is a virulence factor that contributes to the formation of a distinct hemolytic ring on blood cells agar plates in high concentrations of salt with [D]{.smallcaps}-mannitol as the carbon source, known as the "Kanagawa phenomenon" (KP; [@B62]; [@B111]). In the past, the KP has been regarded as an important indicator in the identification of the pathogenic and non-pathogenic *V. parahaemolyticus* strains ([@B180]; [@B115]). However, the detection of *V. parahaemolyticus* based on KP is time-consuming, labor intensive, and unreliable, and involves the evaluation of large numbers of samples ([@B120]; [@B162]). Therefore, the development of specific, sensitive, and rapid methods to detect this bacterium is crucial for public health.

PCR DETECTION
-------------

Polymerase chain reaction (PCR) assays are being increasingly used to identify and distinguish specific pathogenic bacteria. Multiplex PCR protocols targeting the *toxR*, *tlh*, *tdh*, *trh*, and *fla* genes have been developed to detect the total and pathogenic *V. parahaemolyticus* from clinical and environmental samples ([@B137]; [@B70]; [@B161]; [@B67]). Recently, a serogroup-*O*-specific PCR assay was used to detect and identify *V. parahaemolyticus* pathogens in clinical and environmental samples ([@B25]). Before 2012, multiplex real-time PCR with different fluorescent probes was used to detect total and pathogenic *V. parahaemolyticus* in different kinds of seafood ([@B168]; [@B112]; [@B159]; [@B136]). Garrido used multiplex real-time PCR to detect pathogenic *V. parahaemolyticus* in water and food samples. The limits of detection for this method were 0.24 CFU/g for *tdh*, and 0.44 CFU/g for *trh1*, and 0.52 CFU/g for *trh2* ([@B42]). A quantitative PCR method combined with propidium monoazide has also been used to quantify the viable *V. parahaemolyticus* cells in raw seafood ([@B184]). In general, detection methods based on PCR are quick, high accuracy and sensitivity, but the main disadvantages of that is badly controllability, and the PCR system often need to be optimized to gain the best detection results ([@B87]).

Loop-mediated isothermal amplification (LAMP) is a specific and highly sensitive technique for DNA amplification under isothermal conditions with the specific primers, and has been widely used to detect pathogenic bacteria in food ([@B181]; [@B130]). LAMP targeting the *tlh*, *tdh*, or *toxR* genes of *V. parahaemolyticus* is used for the sensitive and rapid detection of *V. parahaemolyticus* ([@B172]; [@B109]; [@B26]). A novel LAMP *in situ* detection method was reported for the rapid detection of food-borne *V. parahaemolyticus* strains, which has greater specificity and is less time-consumption than regular LAMP and other PCR-based methods ([@B163]). Recently, [@B177] developed a novel method that combines the LAMP assay with immunomagnetic separation to detect *V. parahaemolyticus* in raw oysters. The limit of detection was 0.19 CFU/g, thus providing a platform for the comprehensive detection of pathogenic strains using a virulence- gene-specific LAMP assay ([@B177]). Although LAMP is an effective and economic method to rapidly detect the pathogenic bacteria at one temperature without the need of cycling, however, similar to PCR, the methods of targeted separation and enrichments severally affected the application of LAMP.

IMMUNOLOGICAL DETECTION
-----------------------

Immunological methods based on monoclonal antibodies are often used for the rapid detection and quantification of food-borne pathogens in seafood. Sandwich enzyme-linked immunosorbent assays based on monoclonal antibodies directed against TDH, TLH, and TRH have been used to identify these proteins in pathogenic clinical isolates of *V. parahaemolyticus* ([@B65], [@B64]; [@B83]; [@B138]). However, these monoclonal antibodies do not detect all clinical and environmental *V. parahaemolyticus* strains because they cross-react with other bacteria ([@B126]). An immunochromatographic assay was developed to detect the TDH hemolysin produced by *V. parahaemolyticus* in enrichment cultures from stool specimens ([@B78]).

Today, recombinant antibody fragments, such as single-chain variable fragments (scFvs), have become an essential tool for research, diagnostic, and therapeutic purposes ([@B166]). In 2012, our group has screened a high affinity scFv antibody successfully against a pathogenic factor TLH of *V. parahaemolyticus* by phage display. The screened scFv-LA3 antibody is specific to TLH antigen, and it is active against *Vibrio* cells possessing TLH ([@B165]). Our results indicated that scFv-LA3 recognizes specifically TLH produced by *V. parahaemolyticus* ([@B166]), and it can be used as an antibody reagent to detect the TLH producing *V. parahaemolyticus* strains in seafood ([@B165]). Compared to the traditional full length Ig G antibody, the sensitivity of immunological method based on scFv is unsatisfactory, and the fact that current scFv antibodies have the poor stability, low solubility, and affinity seriously limits their diagnostic and clinic application. To improve the stability and solubility of scFv antibody, researchers have developed an Skp co-expressed system to express a functional scFv protein, and the Skp co-expressed scFv showed high solubility and binding activity to antigen TLH ([@B164]).

OTHERS METHODS
--------------

In addition to the methods discussed above, many detection methods based on biochemistry and biophysics have been used to detect and identify *V. parahaemolyticus* strains. As early as [@B151], a chromogenic medium was used for the selective and specific detection of *V. parahaemolyticus* strains. [@B53], developed a novel method for the early detection of viable and TDH- or TRH-producing *V. parahaemolyticus* in seafood using soft-agar-coated filter combined with multiplex PCR, which identifies seafood samples contaminated with *V. parahaemolyticus* within 2 days. A new enrichment broth containing the bile salt, sodium taurocholate (ST broth) was used for improving the isolation and detection of pathogenic *V. parahaemolyticus* from seafood ([@B131]). A novel light-scattering sensor based solid agar plate has also been used for the real-time detection and identification of *V. parahaemolyticus*, *V. vulnificus*, and *V. cholerae* colonies ([@B68]). Dual-color flow cytometry was developed for the simultaneous detection of *V. parahaemolyticus* and *Salmonella typhimurium* in real samples. In this system, fluorescent quantum dots (QDs) labeled aptamers recognize the two bacterial species, and the sensitivity of detection was increased when QDs nanoparticles was used ([@B38]). Recently, [@B170] developed a real-time resistance measurement based on four different methods of detection *V. parahaemolyticus* by targeting the lecithin-dependent hemolysin gene: including LAMP, electrochemical ion bonding (crystal violet and Mg^2+^), real-time monitoring, and derivative analysis. The limit of detection was 10 CFU/mL, and the results revealed that this method is more accurate, sensitive, and specific than culture methods.

PREVENTION AND CURES BASED ON VIRULENCE FACTORS
===============================================

ANTIBODY NEUTRALIZATION AND INHIBITION
--------------------------------------

Given the widespread contamination by *V. parahaemolyticus* and because it is strongly pathogenic to humans, it is very important to prevent and treat the diseases caused by this bacterium. However, to date, no effective measures are available to treat the diseases caused by *V. parahaemolyticus*, and the prospect of developing such therapies is still not good. Excitingly, antibody molecules have become extremely potent candidates for therapeutic applications, and have been developed into an important class of drugs for the treatment of numerous infectious diseases ([@B50]). An scFv antibody directed against the pathogenic factor TLH of *V. parahaemolyticus* effectively neutralized the cytotoxicity of *V. parahaemolyticus* TLH, thus exerting a protective effect on various types of TLH-infected cells ([@B165]). In *V. parahaemolyticus*, the needle complex is formed by the needle subunit protein (VP1694), which contains only 88 amino acids, and its function only relies on a single polymerized protein ([@B155]; [@B9]). The needle subunit may be a useful target protein for screening an effective antibody or inhibitor that can prevent the formation of the needle complex ([@B34]). A specific and high-affinity scFv antibody directed against VP1694 (needle subunit) has been prepared, and may play an important role in inhibiting the assembly of T3SS ([@B167]). Significantly, the above results showed that the specific and functional scFv antibodies against target antigens of *V. parahaemolyticus* have been prepared successfully, and it provides a solid foundation for the immunological diagnosis and prevention of the diseases caused by *V. parahaemolyticus.*

INHIBITOR-MEDIATED TARGETED THERAPIES
-------------------------------------

Type III secretion systems is conserved among different bacterial pathogens, and it may be an important potential therapeutic target ([@B44]; [@B104]). Like other Gram-negative pathogenic bacteria, *V. parahaemolyticus* contains a contact-dependent T3SS, which delivers several effectors into the cytosol of infected host cells ([@B94]; [@B118]; [@B153]; [@B169]). The above description shows that T3SS might be a useful target for screening an effective inhibitor that can prevent the formation of the needle complex.

Many small chemical molecules have been shown to block assembly of T3SS, and some compounds broadly inhibit T3SS in many other bacterial pathogens ([@B69]). A high-throughput assay was developed to screen for a specific transcriptional inhibitor of the virulence factors in enteropathogenic *Escherichia coli*, to block the promoters of virulence associated factors and thus inhibit their transcription ([@B44]). Sulfonyl amino benzanilides and salicylidene anilides have been shown to inhibit the expression of T3SS- related genes, disrupting different pathways in enteropathogenic *E. coli* ([@B77]; [@B44]). Benzimidazoles also have also been shown to inhibit the transcription factors LcrF of *Yersinia pseudotuberculosis* and ExsA of *Pseudomonas aeruginosa* ([@B43]; [@B49]). Salicylidene acylhydrazide and thiazolidinone have been used to repress the formation and assembly of the needle complex, and to block the secretion of effectors in many bacterial pathogens, including *Shigella*, *Yersinia*, *Chlamydia,* and *Salmonella* spp. ([@B108]; [@B160]; [@B1]). Other studies have suggested that thiazolidinones are multifaceted therapeutic agents for inhibiting bacterial infection ([@B35]). In summary, the prevention and control of the diseases caused by *V. parahaemolyticus* mainly involve the use of antibiotics, or chemical molecules/drugs, but these inhibitors based on chemical molecules often lead to bacterial drug resistance or environmental residues of drug, resulting in enormous damage to the environment and human health ([@B121]; [@B149]). Hence, it is very important to develop a feasible measure to improve this dilemma.

BACTERIOPHAGE-BASED THERAPIES
-----------------------------

The increasing prevalence of bacterial antibiotic resistance has prompted a search for candidate agents to replace antibiotics in the effective treatment of bacterial diseases. In recent years, therapies based on bacteriophages have become a topical issue in this field. With the development of phage biology research and genome sequencing, theses methods have been applied to the diagnosis and treatment of bacterial diseases ([@B84]; [@B148]). A mycobacteriophage delivered by a non-virulent *Mycobacterium* was reported to effectively kill the *M*. *avium* and *M*. *tuberculosis*, and has become a model for phage therapies directed against intracellular bacterial pathogens ([@B14]; [@B123]). The therapeutic efficacy of phage therapies has been demonstrated in many infectious diseases caused by members of the genus *Vibrio*, including *V. vulnificus*, *V. harveyi, V. parahaemolyticus,* and *V. anguillarum* ([@B146]; [@B31]; [@B97]). Phage therapy can protect against experimentally induced vibriosis in the Atlantic salmon, and can effectively prevent mortality during vibriosis of in the brine shrimp and *V. anguillarum* infections during the production of fish larvae ([@B57]; [@B95]; [@B149]). Unlike antibiotics or chemical drugs, phage therapies are inexpensive, and more environmentally friendly, and do not induce microbial resistance, suggesting that phage therapy is a suitable alternative treatment for vibriosis in aquaculture industries ([@B149]). One of the main challenges in using bacteriophages to control pathogens in seafood is to control the efficacy and safety of phage, and the market acceptance of use of phage. The detailed characterization of phage properties and understanding of phage--host interactions are essential requirements for the successful application of phage-based pathogen control ([@B156]).

CONTROLS AND PREVENTION
-----------------------

To reduce the risk of *V. parahaemolyticus* infections associated with seafood consumption, some strategies based on physical and chemical methods have been developed ([@B152]). Thermal processing is a common approach to inactivating *V. parahaemolyticus* residues in seafood. Low-temperature freezing (at --18°C or --24°C) or high-temperature treatment (\>55°C) for 10 min is reported to effectively inactivate or kill *V. parahaemolyticus* in oysters ([@B4]). High-pressure processing (HPP) is another method that has also been used to destroy pathogenic microorganisms in seafood, and has been used extensively to inactivate *V. parahaemolyticus* in oysters ([@B19]; [@B27]; [@B54]). Irradiation is another important method of eliminating *V. parahaemolyticus* from oysters. It does not kill the oyster or alter its sensory qualities at low doses, but the safety issues associated with radioactive materials limits its use ([@B3]; [@B71]). Similar to the approaches discussed above, chemical reagents have been developed to reduce the bacterial contamination in seafood, including chlorine, electrolyzed oxidizing water and iodophors ([@B30]; [@B133]). However, none of these effectively dislodge *V. parahaemolyticus* from oysters, and further research is required that focuses on the screening and development of new drugs.

CONCLUSION
==========

*Vibrio parahaemolyticus* occurs naturally in marine, estuarine, and coastal environments throughout the world, and is the causative agent of food-borne gastroenteritis ([@B21]). The T3SSs are responsible for its cytotoxicity, and play a significant role in the induction of inflammatory chemokines in the host. T3SS1 is essential for systemic infection and the innate immune responses induced during intestinal infection, although the details of the mechanisms are still unclear, and the host targets remain to be determined ([@B113]). T3SS2 is associated with the enterotoxicity of *V. parahaemolyticus* in mammalian infection models *in vivo*, and has been reported to cause cytotoxicity in intestinal cell lines ([@B52]). The T6SSs, novel recently identified systems are necessary for the adhesion of *V. parahaemolyticus* to cells and are also involved in intracellular trafficking and vesicular transport. T6SS1 has antibacterial activity under warm conditions, enhancing the environmental fitness of *V. parahaemolyticus* ([@B140]), but our knowledge of the biological activity of T6SS2 is limited ([@B140], [@B142]). Although a number of toxins and effectors associated with the pathogenesis of *V. parahaemolyticus* have been identified and characterized, but the detailed mechanisms of the total effectors of this bacterium, which have evolved to work together, and the distinct functions of individual effectors in causing pathogenicity are yet to be investigated. Further studies should focus on the correlation between T3SS and T6SS, and the non-invasive nature of *V. parahaemolyticus* warrants further investigation. Today, a large number of detection methods based on virulence factors are used for the detection and risk assessment of *V. parahaemolyticus.* However, to reduce the harm attributable to *V. parahaemolyticus,* specific, highly sensitive molecular methods are required to reliably identify and differentiate virulent and avirulent *V. parahaemolyticus* strains. The prevention and treatment of the diseases are still the key outcomes of future research, which should extend our understanding of the precise relationship between the disease in the human host and the pathogenicity of *V. Parahaemolyticus*. This review article provides insight into the control of the clinical risks posed by this potently virulent bacterium, which is extremely pathogenic to humans, by summarizing the molecular and therapeutic techniques available to future medical and immunological research. Effective control measures that combine novel drugs and targeted therapies must be developed to eradicate the risks posed to human health by this life-threatening disease exclusively.
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